ÌÇÐÄÆƽâ°æ

Pharma and biotech M&A activity

Statistics report about M&A deals in the pharma and biotech industry

This report presents key facts and figures about mergers and acquisitions in the pharmaceutical and biotech industry worldwide. For biopharmaceutical companies, M&A deals are often essential for generating growth and acquiring knowledge. This report provides a good introduction into the M&A landscape of the industry, including volume, value, and type of deals, as well as an outlook on what trends are expected for 2021.

Download your Report

  We value your privacy and will never rent or sell your email address.

Privacy

Table of contents

Industry overview

5
  • Premium Statistic Pharmaceutical market size worldwide 2001-2029
  • Premium Statistic Global biotech drug sales estimate 2012-2024
  • Premium Statistic Leading 10 biotech and pharmaceutical companies based on market cap 2026
  • Premium Statistic Major 50 pharmaceutical companies - Rx sales and R&D spending 2024
  • Premium Statistic Major pharmaceutical companies 2024, by capex growth

Number of deals

7
  • Premium Statistic Planned and actual healthcare and life sciences activity in 2020, by subsector
  • Basic Statistic Global number of life sciences sector deals 2013-2021
  • Premium Statistic Number of biopharmaceutical deals worldwide 2016-2020, by type
  • Basic Statistic Number of cell and gene therapy deals worldwide 2016-2020, by type
  • Premium Statistic Number of biopharma M&A deals worldwide 2010-2019, by companies
  • Basic Statistic Number of biopharma M&A deals worldwide 2010-2019, by total transaction value
  • Premium Statistic Number of biopharma M&A deals worldwide 2010-2019, by industry

Value of deals

5
  • Premium Statistic Largest M&A pharmaceutical deals ever as of 2024
  • Basic Statistic Global value of life sciences sector deals 2013-2021
  • Basic Statistic Top completed life sciences deals based on value globally 2020
  • Premium Statistic Value of biopharma M&A deals worldwide 2010-2019, by industry
  • Premium Statistic Average value of biopharma M&A deals worldwide 2010-2019, by industry

Mega-merger: BMS/Celgene

5
  • Premium Statistic Bristol-Myers Squibb's revenue 2006-2025
  • Basic Statistic Bristol-Myers Squibb revenue by segment 2015-2020
  • Basic Statistic Celgene's revenue and net income 2006-2018
  • Premium Statistic Revenue of Celgene 2016-2018, by therapeutic area
  • Premium Statistic Top pharma companies worldwide 2026, by size of R&D pipeline

2021 outlook

4
  • Basic Statistic Expected acquisitions of biopharma companies by type of asset 2021
  • Basic Statistic Expected investment in biopharma and diagnostic lab services 2021, by type
  • Basic Statistic Expected valuation changes in healthcare and life sciences 2021, by subsector
  • Premium Statistic Expected investment changes in biopharma and diagnostic lab services 2021
Report this content
FURTHER REPORTS

Recommended and recent reports

Recommended statistics

You may also be interested in...
We’re happy to help

Get in touch with us for additional information

Feel free to contact us anytime. We will respond to your inquiry as quickly as possible.

Get in touch